ArticleJournal of molecular modeling2023

In silico and experimental methods for designing a potent anticancer arazyme-herceptin fusion protein in HER2-positive breast cancer.

Farideh Rahmani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.